Revision of USP Chapter <1094> Capsules - Dissolution Testing And Related Quality Attributes Published for Comments

Recommendation
Monday, 29 September 2025 14.00 - 17.00 h
In the Pharmacopeial Forum, PF 48(4), a new version of USP Chapter <1094> Capsules—Dissolution Testing And Related Quality Attributes was published.
The chapter provides approaches for the development of dissolution test procedures for capsules. It also discusses quality attributes associated with capsules that may affect the outcome of dissolution testing.
Based on comments received on the version of the chapter official as of December 1, 2020, several revisions are being proposed. These include:
- References to USP chapter <1711> (Oral Dosage Forms—Performance Tests) and to FDA guidance on dissolution testing (Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances) were inserted
- The following four subchapters have been added:
- 4.1 Cleaning Considerations
- 5.6 In vitro in vivo Correlations
- 6.3 Brittleness
- 6.4 Overall Potential Capsule Defect Assessment. - Additional information, recommendations and examples have been added to various sections of the document.
In addition, minor editorial changes have been made.
Further information and a more detailed summary of the proposed revisions can be found in the document published on PF Online. The deadline for submitting comments is 30 September 2022.
Related GMP News
15.09.2025USP-NF Stimuli Article on Apex Vessels used in Dissolution Testing: Corrected Version Published
27.08.2025FDA Warning Letter: Missing Identity Tests, Unverified CoAs, and Inadequate DEG/EG Controls
20.08.2025USP Responds to Comments on Chapter <202> HPTLC Identification of Fixed Oils
13.08.2025USP publishes Comments rereived on Chapter <317>
13.08.2025FDA Issues Warning Letter to Contract Testing Laboratory for Inadequate OOS Investigations
06.08.2025EMA publishes Overview of Comments received on ICH M13B Guideline on Bioequivalence